TrialsgrambetaRCTs are beautiful

Reboli (anidulafungin)

2007

Anidulafungin versus Fluconazole for Invasive Candidiasis

In 245 patients with invasive candidiasis, anidulafungin was superior to fluconazole for global response at end of intravenous therapy.

Result

Global response at end of intravenous therapy
Absolute difference
15.4 points

The absolute difference is derived from the event rates.

Also reported: Superiority of the echinocandin.

Original publication
Subtopic
Candidaemia
Design
Double-blind RCT
Relevance
Important: one of several pillars.
Source
Reboli AC, et al. N Engl J Med. 2007;356(24):2472-2482.doi 10.1056/NEJMoa066906

Discussion & critique

Established echinocandins as first-line therapy for candidaemia. Step-down to fluconazole only in stable patients with susceptible isolates.